FLUORODOPA F18 Drug Patent Profile
✉ Email this page to a colleague
When do Fluorodopa F18 patents expire, and what generic alternatives are available?
Fluorodopa F18 is a drug marketed by Feinstein and is included in one NDA.
The generic ingredient in FLUORODOPA F18 is fluorodopa f-18. One supplier is listed for this compound. Additional details are available on the fluorodopa f-18 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUORODOPA F18?
- What are the global sales for FLUORODOPA F18?
- What is Average Wholesale Price for FLUORODOPA F18?
Summary for FLUORODOPA F18
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 12 |
Clinical Trials: | 12 |
Patent Applications: | 140 |
DailyMed Link: | FLUORODOPA F18 at DailyMed |
Recent Clinical Trials for FLUORODOPA F18
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Andrew Newberg | Phase 2 |
Thomas Jefferson University | Phase 2 |
Washington University School of Medicine | Phase 1 |
US Patents and Regulatory Information for FLUORODOPA F18
FLUORODOPA F18 is protected by zero US patents and two FDA Regulatory Exclusivities.
FDA Regulatory Exclusivity protecting FLUORODOPA F18
EXCLUSIVITY ON THIS APPLICATION EXPIRING ON THIS DATE HAS BEEN WAIVED BY SPONSOR - SEE SECTION 1.8 OF ORANGE BOOK PREFACE WAIVED EXCLUSIVITY
Exclusivity Expiration: ⤷ Sign Up
NEW CHEMICAL ENTITY
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feinstein | FLUORODOPA F18 | fluorodopa f-18 | SOLUTION;INTRAVENOUS | 200655-001 | Oct 10, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |